Skip to content

Comparison and evaluation of the effectiveness of oral captopril and oral hydrochlorothiazide in the treatment of urgency hypertensive patients

Comparison and evaluation of the effectiveness of oral captopril and oral hydrochlorothiazide in the treatment of urgency hypertensive patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200722048172N1
Enrollment
70
Registered
2020-08-10
Start date
2019-09-21
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urgency Hypertension. Essential (primary) hypertension

Interventions

Intervention 1: Intervention group:Taking captopril 25 mg orally and in a single dose. Intervention 2: Intervention group:Take hydrochlorothiazide 25 mg orally and in a single dose.

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with known hypertension with a blood pressure of 160/90 mm Hg or more and patients with the new-onset sever hypertention with a blood pressure of 180/110 mm Hg or more without organ damage (urgency) will be included in the study if satisfied. Patients between the ages of 18 and 65 will be included in the study.

Exclusion criteria

Exclusion criteria: Patients who need intravenous drugs to control their blood pressure or other blood pressure medications for different reasons. Patients who need high dose of ACEIs or ARBs (> 50 mg/d Captopril, > 10 mg/d Enalapril, > 5 g/dLisinopril, > 50 mg/d Losartan, > 80 mg/d Valsartan),to control their blood pressure. Patients with myocardial infarction presenting with acute chest pain. Patients with severe renal or hepatic failure,anuria, papillaryedema, pulmonary edema, loss of consciousness, seizure,aortic dissection, or bilateral renal artery stenosis; pregnantpatients, patients with a history of overt allergy or angioedemawith ACEIs, Allergy to penicillins and sulfonamides.

Design outcomes

Primary

MeasureTime frame
Systolic Blood Pressure. Timepoint: In 10, 20, 30, 45, 60, 90, 120, 180 minutes after drug administration. Method of measurement: With a hand pressure guage and with ascale of millimeters of mercury.;Diastolic Blood Pressure. Timepoint: In 10, 20, 30, 45, 60, 90, 120, 180 minutes after drug administration. Method of measurement: With a hand pressure guage and with ascale of millimeters of mercury.;Mean Blood Pressure. Timepoint: 10, 20, 30, 45, 60, 90, 120, 180 minutes after drug administration. Method of measurement: After measuring systolic and diastolic blood pressure its measured with the sum of twice the diastolic blood pressure and systolic blood pressure divided by three (3 / (2DBP + SBP)) will be calculated.;Heart Rate. Timepoint: 10, 20, 30, 45, 60, 90, 120, 180 minutes after drug administration. Method of measurement: It will be obtained by counting the number of pulses per minute.

Secondary

MeasureTime frame
Satisfaction rate. Timepoint: At intervals and ends of measurements. Method of measurement: Questionnaire.;Drug side effects. Timepoint: At intervals and ends of measurements. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Razavianzadeh

Islamic Azad University

nasrinrazavianzadeh@gmail.com+98 23 3233 9661

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026